RFS
RIGL icon

Rockefeller Financial Services’s Rigel Pharmaceuticals RIGL Stock Holding History

Rockefeller Financial Services’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,495
Closed -$128K – 517
2016
Q3 		$128K Hold
3,495
– – ﹤0.01% 331
2016
Q2 		$78K Buy
+3,495
New +$86.9K ﹤0.01% 375

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Rockefeller Financial Services's RIGL Position: Q4 2016 in Review

Rockefeller Financial Services sold out of Rigel Pharmaceuticals (RIGL) in Q4 2016, closing a stake of 3,495 shares — an estimated $128K sold.

Rockefeller Financial Services first reported a position in RIGL in Q2 2016 and held it in 2 quarters. The position peaked at $128K in Q3 2016. 107 funds tracked by Wall St. Rank hold RIGL as of Q4 2016.

  • Rockefeller Financial Services reported no remaining Rigel Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Rockefeller Financial Services sold 3,495 Rigel Pharmaceuticals shares in Q4 2016, an estimated $128K.
  • Rockefeller Financial Services first reported a position in Rigel Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Rockefeller Financial Services's Rigel Pharmaceuticals position peaked at $128K in Q3 2016.
  • 107 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2016.

Based on Rockefeller Financial Services's 13F filing for Q4 2016, filed 19 Jan 2017.